MedTrace Logo

Vitamin D Replacement in Statin-Induced Myopathy

NCT01400009 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-04-07

No results posted yet for this study

Summary

Pretreating people with replacement doses of vitamin D will allow them to tolerate Statin medications that have caused muscle pain for them in the past.

Conditions

  • HMG COA Reductase Inhibitor Adverse Reaction

Interventions

DRUG

Vitamin D (Cholecalciferol )

10,000 IU tablets. 50,000 initial dose, followed by weekly doses of 10,000 IU

DRUG

Placebo

Standard Placebo made of Lactose 100 mg

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Mark H Sherman, MD,CM · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01400009 on ClinicalTrials.gov